Clinical trial

Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

NCT07584122

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Oral Pre-Exposure Prophylaxis (PrEP) (Tenofovir Disoproxil Fumarate/Emtricitabine) Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Community-Based PrEP Delivery Model Find medicine records · Find other trials using this name

BEHAVIORAL · Unmapped registry intervention Telehealth and mHealth Support Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-09-01

PhaseNA

Conditions

HIV Infectionsunresolved

Interventions

Oral Pre-Exposure Prophylaxis (PrEP) (Tenofovir Disoproxil Fumarate/Emtricitabine)DRUG

Community-Based PrEP Delivery ModelBEHAVIORAL

Telehealth and mHealth SupportBEHAVIORAL

Sponsors & collaborators

Oswaldo Cruz Foundationlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07584122 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.